Gene therapy for primary immunodeficiencies: Part 2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gene therapy for primary immunodeficiencies: Part 2

Published:2012-10 Issue:5 Volume:24 Page:585-591
ISSN:0952-7915
Container-title:Current Opinion in Immunology
language:en
Short-container-title:Current Opinion in Immunology

Author:

Aiuti Alessandro,Bacchetta Rosa,Seger Reinhard,Villa Anna,Cavazzana-Calvo Marina

Funder

European Commission: Advanced Cell-based Therapies for the treatment of Primary ImmunoDeficiency (Cell-PID)

Italian Telethon Foundation

Fondazione Roma

Italian Ministry of Research and University (MIUR)

European Research Council (ERC)

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference54 articles.

1. Gene therapy for primary adaptive immune deficiencies;Fischer;J Allergy Clin Immunol,2011

2. Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency;Ferrua;Curr Opin Allergy Clin Immunol,2010

3. Stem-cell gene therapy for the Wiskott–Aldrich syndrome;Boztug;N Engl J Med,2010

4. Genomic instability and myelodysplasia with monosomy 7 consequent to Evi1 activation after gene therapy for chronic granulomatous disease;Stein;Nat Med,2010

5. Ten years of gene therapy for primary immune deficiencies;Aiuti;Hematology Am Soc Hematol Educ Program,2009

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolving landscape of gene therapy strategies for the treatment of osteoarthritis;Osteoarthritis and Cartilage;2024-04

2. Improved functionality and potency of next generation BinMLV viral vectors toward safer gene therapy;Molecular Therapy - Methods & Clinical Development;2021-12

3. Gene therapy in PIDs, hemoglobin, ocular, neurodegenerative, and hemophilia B disorders;Open Life Sciences;2021-01-01

4. Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods;Pharmaceutics;2019-09-01

5. In vitro study of HAX1 gene therapy by retro viral transduction as a therapeutic target in severe congenital neutropenia;European Cytokine Network;2018-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3